Congratulations to the 2017 SYNERGY Community Engagement Research Pilot Grant awardees! This program facilitates collaborative translational research studies across Dartmouth and affiliated health centers and communities.
Listen here – As a guest on “Vermont Edition,” William Hudenko, assistant professor of psychiatry and adjunct assistant professor of the department of psychological and brain sciences, discusses software and app, called Proxi, that he created that allows patients to create online networks of friends, relatives and doctors—and share information among them. It also simplifies the process of legally authorizing that information to be shared with different people.
Read article – The Geisel School of Medicine and four additional New Hampshire schools have rolled out a program that’s aimed at preventing drug addiction in patients before it starts. The practice is called SBIRT, which stands for screening, brief intervention and referral to treatment. John Damianos ’16, Geisel ’20, said the approach fosters self-reflection, and reduces feelings of shame and stigma.
Read article – A segment about the Geisel School of Medicine’s recent Match Day Ceremony in which fourth-year medical students learned where they will go to complete their residencies. The segment features comments by Duane Compton, interim dean of the Geisel School of Medicine and professor of biochemistry and cell biology, as well as comments by fourth-year medical students Sophie Leung, Liam Guerin, Asia Peek, and Lovelee Brown.
Read article – Features an interview with Mariétou Ouayogodé, post-doctoral fellow at the Dartmouth Institute for Health Policy and Clinical Practice, who discusses how the increased emphasis that the Affordable Care Act and Medicare accountable care organizations (ACOs) placed on prevention is important in reducing the high cost of older patients, especially as the baby boomer generation reached retirement age.
Read article – An opinion piece by Kendall Hoyt, assistant professor of medicine and lecturer at the Thayer School of Engineering, where she discusses how biosecurity and cybersecurity have similar dangers—and similar potential benefits. “In the wrong hands, both types of knowledge can be used to develop a weapon instead of a vaccine or a patch,” says Hoyt. “The genetic tools and exploit software that enable these activities are becoming easier to use and to acquire, prompting security experts to ask one question with growing urgency: How can we protect against misuse without limiting discovery and innovation?”
Read article – Quotes Elliott Fisher, director of the Dartmouth Institute for Health Policy and Clinical Practice, and professor of medicine and of community and family medicine, in an article that examines why the federal government should train more doctors. Fisher, who helped develop the accountable care organization model, said residency training “responds to the market.” Hospitals may be incentivized to fund training programs that perform profitable procedures, such as orthopedic surgery, whose doctors are not in short supply, Fisher said. There’s less financial incentive to invest in specialties like primary care, which are experiencing a shortage.
Join Dartmouth Institute students in celebrating National Public Health Week 2017. Sponsored by the Student Advisory Council, the week-long series of events includes a kickoff talk by Dartmouth undergraduate and Geisel alumnus John Lawrence, MD, DC’76, MED’79, president of the U.S. section of Doctors Without Borders.
SYNERGY announces the 2017 SYNERGY Scholars Award, an ongoing Mentored Career Development Program modeled on the NIH KL2 Scholars Program. This opportunity combines didactic training, mentoring, exposure to multidisciplinary research, and ongoing evaluation to prepare junior investigators for careers in Clinical and Translational Research.
Read article – Quotes H. Gilbert Welch, professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, and professor of economics, about cancer survival rates as screening has improved. “Ironically, the more overdiagnosis that a screening test does, the more popular it becomes, because there’s more people who feel they are ‘survivors’ because of screening,” says Welch. “Although it happens to be a cancer that was never going to bother them. They’ll never know that.”